[1]
Xia, Z. 2024. To explore the therapeutic effects of shRNA1 and shRNA4 on Parkinson’s disease mice based on the mutation of the SNCA gene of α-synuclein. MedScien. 2, 5 (Oct. 2024), 2262. DOI:https://doi.org/10.61173/mqe84141.